Who makes Cabotegravir Formulation I?

Cabotegravir Formulation I is developed by ViiV Healthcare.

What development phase is Cabotegravir Formulation I in?

Cabotegravir Formulation I is in Phase 1.

Last reviewed 2026-04-19 · How we verify

Cabotegravir Formulation I

ViiV Healthcare · Phase 1 active Small molecule

At a glance

Generic name	Cabotegravir Formulation I
Sponsor	ViiV Healthcare
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Cabotegravir Formulation I CI brief — competitive landscape report
Cabotegravir Formulation I updates RSS · CI watch RSS
ViiV Healthcare portfolio CI